Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs58269521 | chr17:74663258 | G/T | 1.08E-6 | 172 | 25.4 | 22.63 | 10.28 | KM Plot |
PCPG | rs58291918 | chr17:65798803 | T/C | 0.000381 | 176 | 24.5 | 36 | 8.22 | KM Plot |
PCPG | rs58301703 | chr2:136532225 | G/A | 3.13E-5 | 174 | 25.87 | 25.87 | 9.72 | KM Plot |
PCPG | rs5833726 | chr2:118534146 | C/CT | 1.57E-5 | 178 | 25 | 30.93 | 11.65 | KM Plot |
PCPG | rs58381304 | chr7:158680197 | A/G | 0 | 175 | 25.47 | 21.9 | 3.17 | KM Plot |
PCPG | rs58382074 | chr12:21624732 | GGCTATT/G | 3.9E-8 | 170 | 25.28 | 33.73 | 2.28 | KM Plot |
PCPG | rs58385680 | chr2:61558925 | T/TA | 0.000478 | 178 | 23.43 | 30.33 | 17.85 | KM Plot |
PCPG | rs58441032 | chr2:24309084 | G/A | 0.00011 | 178 | 25.28 | 26.92 | 17.43 | KM Plot |
PCPG | rs5844450 | chr22:21278844 | GA/G | 7.74E-5 | 177 | 12.93 | 31.47 | 25.2 | KM Plot |
PCPG | rs584798 | chr13:37505317 | A/G | 0.000352 | 177 | 6.37 | 24.85 | 25.7 | KM Plot |
PCPG | rs58483454 | chr1:40519353 | A/T | 0.000312 | 175 | 25.2 | 27.78 | 25.17 | KM Plot |
PCPG | rs584873 | chr1:36431806 | C/A | 0.000208 | 173 | 25.67 | 24.7 | 10.3 | KM Plot |
PCPG | rs5848991 | chr3:53528230 | G/GA | 0.000225 | 171 | 31.43 | 20.2 | 25.87 | KM Plot |
PCPG | rs5852856 | chr3:136668682 | AT/A | 0.000403 | 172 | 20.2 | 27.82 | 23.43 | KM Plot |
PCPG | rs58534852 | chr16:89975911 | C/G | 0.00018 | 174 | 25.87 | 20.28 | 3.17 | KM Plot |